Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study — Gabriel Tremblay (2021) | RDL Network
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
Article 2021 en
Authors
GT
Gabriel Tremblay
PD
Patrick Daniele
JB
Janis L. Breeze
Abstract
1 min read
This trial was registered on ClinicalTrials.gov under the trial-ID NCT02336815 on January 8, 2015.
Stefan Knop, María‐Victoria Mateos, Meletios A Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Chantal Doyen, Paulo Lúcio, Zsolt Nagy, Ganna Usenko, Luděk Pour, Mark Cook, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung‐Soo Yoon, Genadi Losava, Tomoaki Fujisaki, Mamta Garg, Jianping Wang, Susan Wróblewski, Anupa Kudva, Katharine S. Gries, John Fastenau, Jesús F. San Miguel, Michèle Cavo
Sundar Jagannath, Dan T. Vogl, Meletios A Dimopoulos, Ajay K. Nooka, Carol Ann Huff, Philippe Moreau, Craig E. Cole, Josh Richter, David Dingli, Ravi Vij, Sascha A. Tuchman, Marc‐Steffen Raab, Katja Weisel, Michel Delforge, David Kaminetzky, Robert F. Cornell, A. Keith Stewart, James E. Hoffman, Kelly Godby, Terri L. Parker, Moshe Levy, Martin Schreder, ,
Dan T. Vogl, Ajay K. Nooka, Maria Gavriatopoulou, Andrew J. Yee, Carol Ann Huff, Philippe Moreau, David Dingli, Craig E. Cole, Paul G. Richardson, Meletios A Dimopoulos, Sagar Lonial, Keith Stewart, Ajai Chari, Joshua Richter, Noa Biran, David S. Siegel, Jianjun Liu, Anita Joshi, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Sundar Jagannath
Lisa Leypoldt, Maria Gavriatopoulou, Britta Besemer, H. Salwender, Marc‐Steffen Raab, Axel Nogai, Cyrus Khandanpour, V. Runde, Manola Zago, Peter Martus, H. Goldschmidt, Carsten Bokemeyer, Meletios A Dimopoulos, Katja Weisel
Discussion(0)
No comments yet. Be the first to comment.